HH Biotechnology Holdings Company

OTCPK:HHBT Stock Report

Market Cap: US$1.4k

HH Biotechnology Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Sheng Jiang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.3yrs
CEO ownershipn/a
Management average tenure8.3yrs
Board average tenure8.4yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Sheng Jiang

8.3yrs

Tenure

Mr. Sheng Jiang has been Chief Executive Officer and Director at HH Biotechnology Holdings Company since September 9, 2016.

Leadership Team

NamePositionTenureCompensationOwnership
Sheng Jiang
Chief Executive Officer and Director8.3yrsno datano data
Li Rong Wang
Chief Financial Officer8.3yrsUS$12.39kno data
Liang Zou
Vice President of Operations8.3yrsno datano data
Yee Tang
Investor Relations Officerno datano datano data
Sasaki Koji
Vice President of Marketing8.3yrsno datano data

8.3yrs

Average Tenure

Experienced Management: HHBT's management team is seasoned and experienced (8.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sheng Jiang
Chief Executive Officer and Director8.3yrsno datano data
Jiang Fang
Chairman9.7yrsno datano data
Yizhao Zhang
Independent Director8.6yrsno datano data
Ying Huang
Director8.3yrsno datano data

8.4yrs

Average Tenure

Experienced Board: HHBT's board of directors are considered experienced (8.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 15:42
End of Day Share Price 2024/09/30 00:00
Earnings2016/09/30
Annual Earnings2015/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

HH Biotechnology Holdings Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.